Introduction {#Sec1}
============

Biohydrogen is biologically derived molecular hydrogen and is considered a possible replacement for fossil fuels (Benemann [@CR3]). *Escherichia coli* produces hydrogen gas predominantly under fermentative conditions (Sargent [@CR23]) using the formate hydrogenlyase complex that couples formate oxidation to hydrogen evolution (McDowall et al. [@CR19]). One possible approach to engineering additional routes to hydrogen production in *E. coli* is the heterologous expression of non-native enzymes. An attractive proposition for engineering additional hydrogen metabolism into *E. coli* is to assemble functional NADH-dependent hydrogenases (Ghosh et al. [@CR11]; Kelly et al. [@CR16]), which would not compete directly with native sources of reductant for hydrogen production and potentially link the new hydrogenase activity directly into the anaerobic metabolism of the host organism. This is because when *E. coli* is cultured fermentatively a major metabolic challenge for the cell is the recycling of the NADH produced by glycolysis. This process is normally carried out, in the main, by the aldehyde/alcohol dehydrogenase AdhE.

The Knallgas bacterium *Ralstonia eutropha* (also called *Cupriavidus necator*) contains a soluble cytoplasmic enzyme that links NAD^+^/NADH directly to H~2~ biochemistry (Burgdorf et al. [@CR6]). The *R. eutropha* soluble hydrogenase (SH) is encoded by the *hoxFUYHWI* operon where HoxFU represent the diaphorase half of the enzyme; HoxYH is the \[NiFe\]-hydrogenase half; HoxI is a sixth subunit of the enzyme; and HoxW is a maturation protease required for final activation of the \[NiFe\]-hydrogenase catalytic subunit, HoxH (Burgdorf et al. [@CR6]). Biosynthesis of the Ni--Fe--CO--2CN^−^ cofactor located at the active site of a hydrogenase requires the activity of specific 'maturase' proteins (Böck et al. [@CR5]). These include HypA and HypB (which are involved in nickel processing); the chaperone HypC; and HypD, HypE and HypF, which together build the Fe--CO--2CN^−^ half of the cofactor (Böck et al. [@CR5]). In *R. eutropha* there are at least two versions of most maturase genes available, together with an extra accessory protein of less clearly defined function, HypX (Burgdorf et al. [@CR6]; Schiffels et al., [@CR25]). Some reports suggest that the *R. eutropha* maturases are very specific for the assembly of their cognate \[NiFe\]-hydrogenases (Burgdorf et al. [@CR6]; Schiffels et al. [@CR25]) and this is consistent with the hypothesis that different prokaryotic species require their own dedicated maturase machineries (Böck et al. [@CR5]; Lubitz et al. [@CR17]).

In this work, a synthetic biology approach was taken to producing an active *R. eutropha* soluble hydrogenase in an *E. coli* host. Synthetic operons encoding the SH and hydrogenase maturases were designed and characterised. An active SH was produced and hydrogen production was recorded.

Materials and methods {#Sec2}
=====================

Strain and plasmid generation {#Sec3}
-----------------------------

Plasmids and bacterial strains used are listed in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}, respectively. IC011 was constructed by modifying the IC010 strain (Deplanche et al. [@CR9]) using a Δ*hybOA* allele present on the pMAK705 derivative pRAT58 and the method of Hamilton et al. ([@CR12]). HJ001 (as IC011, Δ*iscR*) and HJ002 (as IC011, Δ*iscR*, Δ*adhE*) were assembled by moving the pMAK705-based Δ*iscR* and Δ*adhE* alleles constructed by Kelly et al. ([@CR16]) sequentially into IC011 by homologous recombination (Hamilton et al. [@CR12]). Synthetic operons were constructed in silico using the *OPTIMIZER* software (Puigbo et al. [@CR21]). A ribosome binding site and linker (5′-AGGAGGAAAAAAAA-3′) was added before each synthetic gene (Kelly et al. [@CR16]) and restriction sites placed at each ends of the gene. The final sequence was then synthesised by Biomatik Corp (USA) and sub-cloned into various expression vectors (Table [1](#Tab1){ref-type="table"}).Table 1Plasmids used and constructed in this workPlasmid nameDetailsAntibiotic resistanceReferencespUNI-PROMAs pT7.5 Tabor and Richardson ([@CR27]) with *tatA* promoter and RBS cloned EcoRI--BamHIAmpJack et al. ([@CR14])pSU-PROMAs pSU40 Bartolome et al. ([@CR2]) with *tatA* promoter and RBS cloned EcoRI--BamHIKanJack et al. ([@CR14])pUNI-SHAs pUNI-PROM with synthetic *hoxFUYHWI* operon cloned BamHI--HindIIIAmpThis workpUNI-A2-XAs pUNI-PROM with synthetic *hypA2B2F2C1D1E1X* operon cloned BamHI--HindIIIAmpThis workpSU-A2-XAs pSU-PROM with synthetic *hypA2B2F2C1D1E1X* cloned BamHI--HindIIIKanThis workpUNI-A1-XAs pUNI-PROM with synthetic *hypA1B1F1C1D1E1X* cloned BamHI--HindIIIAmpThis workpSU-A1-XAs pSU-PROM with synthetic *hypA1B1F1C1D1E1X* cloned BamHI--HindIIIKanThis workpQE80-SHAs pQE80 (Qiagen) with synthetic *hoxFUYHWI* operon cloned BamHI--HindIIIAmpThis workpGP1-2Encoding T7 polymerase under a temperature-dependent promoterKanTabor and Richardson ([@CR27]) Table 2*E. coli* strains used and constructed in this studyStrainRelevant genotypeAntibiotic resistanceSource/referencesMC4100F^−^, *araD139*, Δ(*argF*-*lac*)U169, *ptsF25*, *deoC1*, *relA1*, *flbB5301*, *rspL150*NoneCasadaban and Cohen ([@CR8])IC010As MC4100, ∆*hyaB*, ∆*hycE*NoneDeplanche et al. ([@CR9])IC011As MC4100, ∆*hyaB*, ∆*hybOA*, ∆*hycE*NoneThis workHJ001As MC4100, ∆*hyaB*, ∆*hybOA*, ∆*hycE*, ∆*iscR*NoneThis workHJ002As HJ001, ∆*adhE*NoneThis workBEF314As MC4100, ∆*hypB*-*E*::*cam*CamJacobi et al. ([@CR15])BW25113F^−^, Δ(*araB*--*D*)567, Δ(*rhaD*--*B*)568, Δ*lacZ4787*(::*rrnB*-*3*), *hsdR514*, *rph*-*1*NoneBaba et al. ([@CR1])JW2696As BW25113, Δ*hypA*::*kan*KanBaba et al. ([@CR1])JW2697As BW25113, Δ*hypB*::*kan*KanBaba et al. ([@CR1])JW2698As BW25113, Δ*hypC*::*kan*KanBaba et al. ([@CR1])JW2699As BW25113, Δ*hypD*::*kan*KanBaba et al. ([@CR1])JW2700As BW25113, Δ*hypE*::*kan*KanBaba et al. ([@CR1])JW5433As BW25113, Δ*hypF*::*kan*KanBaba et al. ([@CR1])K38HfrC, *phoA4*, *pit*-10, *tonA22*, *ompF627*, *relA1*, λ^+^NoneLyons and Zinder ([@CR18])

^35^S-methionine radiolabelling {#Sec4}
-------------------------------

Briefly, *E. coli* strain K38 \[pGP1-2\] was transformed with the vectors to be tested. Cultures were grown at 30 °C in M9 minimal medium (Sambrook and Russell [@CR22]), containing all amino acids except methionine and cysteine, before transcription of T7 RNA polymerase was induced by heat shock at 42 °C for 15 min. Rifampicin was then added to inhibit the native RNA polymerase activity and a 1 ml aliquot was spiked with 0.01 μCi of ^35^S-Methionine. After incubating for 15 min, samples were heated to 105°C, separated by SDS-PAGE, fixed and visualised by autoradiography.

Enzyme assays {#Sec5}
-------------

In vitro hydrogen oxidation activity was measured spectrophotometrically using the H~2~-dependent reduction of methyl viologen (MV) in anaerobic cuvettes (Palmer et al. [@CR200]). Strains were grown anaerobically at 37 °C without agitation for 16 h in 500 ml Duran bottles containing LB media supplemented with 0.4% (w/v) fumarate, 0.5% (v/v) glycerol and appropriate antibiotics. Cells were harvested by centrifugation at 2773×*g*, washed twice in 50 mM Tris.HCl pH 7.8, and the wet weights of cell pellets recorded. Pellets were then suspended in 3 ml 50 mM Tris.HCl pH 7.8 before lysis by French Press (8000 psi) and crude extracts prepared by centrifugation.

For in vivo hydrogen production assays, Hungate tubes containing 5 ml M9 media supplemented with 0.8% (w/v) glucose and 0.2% (w/v) casamino acids were inoculated with 50 μl of pre-culture. Tubes were then inverted and incubated without agitation at 37 °C for 72 h. Headspace hydrogen was quantified using a gas chromatograph (Shimadzu GC-2014). Nitrogen was used as the carrier gas with a flowrate of 25 ml min^−1^, and the total amount of hydrogen in the headspace (10 ml) was calculated based on a standard curve. Values were normalised by considering the relative optical density of the cultures and the culture volume.

Results {#Sec6}
=======

Synthetic *hox* and *hyp* operons are expressed in *E. coli* {#Sec7}
------------------------------------------------------------

To produce the soluble cytoplasmic \[NiFe\]-hydrogenase from *R. eutropha* in *E. coli* a synthetic operon was designed (Fig. [1](#Fig1){ref-type="fig"}a). The natural *hoxFUYHWI* gene order was maintained, but each synthetic gene was optimised for *E. coli* codon usage. Next, restriction sites were chosen to bookend each gene (Fig. [1](#Fig1){ref-type="fig"}a). The 5811 bp synthetic operon sequence was then synthesised and cloned into pUNI-PROM (Amp^R^), pSU-PROM (Kan^R^) and pQE-80 (Amp^R^) expression vectors (Table [1](#Tab1){ref-type="table"}).Fig. 1Synthetic *hox* and *hyp* operons for expression in *E. coli*. **a** Synthetic *hox* and *hyp* operons encoding the SH complex and associated maturases were designed for optimal expression in *E. coli*. The operons were initially cloned under the control of the constitutive *E. coli tat* promoter and the T7 promoter. Synthetic ribosome binding sites (RBS) were placed before each gene sequence, which had been previously codon optimised. Restriction sites bookended each synthetic gene to allow in-frame deletions to be constructed. ^35^S-Met radiolabelling was carried out in *E. coli* cells carrying either the synthetic *hoxFUYHWI* operon encoding the *R. eutropha* SH (**b**), the *hypA2B2F2C1D1E1X* operon (**c**) and the *hypA1B1F1C1D1E1X* operon (d) encoding *R. eutropha* maturase proteins. **e** The same samples as used in **d** were also subjected to SDS-PAGE on a 7.5% (w/v) polyacrylamide gel in order to get better resolution of protein bands \~40 kDa in relative molecular mass. Single gene deletions were prepared for each plasmid as indicated. Labelling of plasmid-encoded proteins was carried out in whole cells before samples were then separated by SDS-PAGE (12 or 7.5% w/v polyacrylamide), fixed, and visualised by autoradiography. Note that *hypC1* cannot be excised from its synthetic operon

To test whether the *hoxFUYHWI* genes were being transcribed and translated in *E. coli*, the K-38\[pGP1-2\] strain was transformed with the pUNI-SH vector. This allowed T7 polymerase-dependent transcription of the operon and labelling of plasmid-encoded gene products with ^35^S-methionine. The radiolabelling experiments showed that pUNI-SH encodes at least six polypeptides (Fig. [1](#Fig1){ref-type="fig"}b). In order to assign each protein to a specific synthetic gene, a library of in-frame deletion plasmids was prepared. Following ^35^S-Met-labelling experiments, it is clear that the catalytic subunits of the SH HoxF and HoxH are correctly and stably synthesised. The remaining four polypeptides are also synthesised but, except for HoxY, appear to migrate in SDS-PAGE at slightly aberrant apparent molecular masses (Fig. [1](#Fig1){ref-type="fig"}b). However, the banding pattern on SDS-PAGE matches exactly that of previous work on the native (Burgdorf et al. [@CR7]) and recombinant (Schiffels et al. [@CR25]) SH enzyme.

Activation of \[NiFe\]-hydrogenases requires specific maturases to build and insert the \[NiFe\] cofactor (Böck et al. [@CR5]). The *R. eutropha* SH is reported to require the products of *hypA2*, *hypB2* and *hypF2* for activity (Wolf et al. [@CR28]). In addition, *hypC1*, *hypD1*, *hypE1* and *hypX* all have roles to play (Böck et al. [@CR5]; Burgdorf et al. [@CR6]; Schiffels and Selmer [@CR24]). Thus, an 8213 bp synthetic *hypA2B2F2C1D1E1X* operon was assembled (Fig. [1](#Fig1){ref-type="fig"}a) and cloned into pUNI-PROM (Amp^R^) and pSU-PROM (Kan^R^) (Table [1](#Tab1){ref-type="table"}). Construction of plasmid-borne in-frame deletions and in vivo pulse-labelling with ^35^S-methionine established that the maturation proteins were being produced in *E. coli* (Fig. [1](#Fig1){ref-type="fig"}c).

Finally, an alternative *R. eutropha* maturase operon, the 7115 bp *hypA1B1F1C1D1E1X* version, and derivatives were also constructed (Fig. [1](#Fig1){ref-type="fig"}a; Table [1](#Tab1){ref-type="table"}). This synthetic operon was also found to be capable of producing protein product when examined by ^35^S-methionine labelling (Fig. [1](#Fig1){ref-type="fig"}d). Many of the encoded proteins can be readily identified; however, HypF1 (predicted to be 40 kDa) is not clear (Fig. [1](#Fig1){ref-type="fig"}d). A follow-up SDS-PAGE experiment was designed to generate greater separation in the 40 kDa region (Fig. [1](#Fig1){ref-type="fig"}e). In this case, HypB1, HypD1 and HypE1 could be readily identified; however, the synthesis of HypF1 could not be established (Fig. [1](#Fig1){ref-type="fig"}e).

The synthetic maturase operons are functional and can activate *E. coli* \[NiFe\]-hydrogenases {#Sec8}
----------------------------------------------------------------------------------------------

To test functionality of the maturase operons, genetic complementation of *E. coli* mutant strains compromised in \[NiFe\] cofactor biosynthesis was undertaken. The *E. coli* BEF314 strain (Δ*hypBCDE*) is devoid of hydrogenase activity (Jacobi et al. [@CR15]). When BEF314 (Δ*hypB*-*E*) was transformed with plasmids encoding HypA1-X and HypA2-X, fermentative hydrogen production was restored to native levels (Fig. [2](#Fig2){ref-type="fig"}a), indicating that the *E. coli* FHL had been activated.Fig. 2The synthetic maturase operons can complement *E. coli hyp* mutants. **a** *E. coli* strain BEF314 (Δ*hypBCDE*) was transformed with a pSU-PROM vector control (−) or vectors encoding the *hypA1*-*X* synthetic operon (pSUA1-X) or synthetic *hypA2*-*X* operon (pSUA2-X). **b** The Keio collection version of single *E. coli* deletion mutants in each of *hypA*, *hypB*, *hypC*, *hypD*, *hypE* and *hypF* were transformed with either empty vector (−) or pUNI-PROM-based vectors encoding the *hypA1*-*X* synthetic operon (A1-X) or synthetic *hypA2*-*X* operon (A2-X). In all cases, strains were grown fermentatively in M9 minimal media supplemented with 0.8% (w/v) glucose before gas chromatography was used to quantify any H~2~ accumulated in the headspace after 48 h of incubation at 37 °C. The positive control (+) is the *E. coli* strain MC4100. *Error bars* represent SEM (*n* = 3)

Next, individual mutants in each of the *hypA*-*E* and *hypF* genes were examined (Fig. [2](#Fig2){ref-type="fig"}b), beginning with *hypA*. As previously reported (Jacobi et al. [@CR15]), the *hypA* mutant retains some hydrogenase activity (Fig. [2](#Fig2){ref-type="fig"}b). Indeed, under the growth conditions and assay type chosen, here the *hypA* mutant was able to accumulate hydrogen to the same level as the control strains (Fig. [2](#Fig2){ref-type="fig"}b).

HypB is a nickel-binding NTPase (Böck et al. [@CR5]), and fermentative H~2~ production by the *E. coli hypB* mutant is low (Fig. [2](#Fig2){ref-type="fig"}b). This phenotype can be rescued by production of either HypA1-X or HypA2-X (Fig. [2](#Fig2){ref-type="fig"}b), and this demonstrates that both HypB1 and HypB2 are functional.

Next, a Δ*hypC* strain was tested. HypC is a small protein that acts as a bridge between the initial \[NiFe\] cofactor assembly proteins and the empty apoenzyme (Böck et al. [@CR5]). In the hydrogen accumulation assay employed here, the Δ*hypC* mutant is able to demonstrate clear hydrogen production activity (Fig. [2](#Fig2){ref-type="fig"}b). Nevertheless, co-expression of plasmids encoding HypA1-X and HypA2-X returned hydrogen evolution to native levels (Fig. [2](#Fig2){ref-type="fig"}b), suggesting that *R. eutropha* HypC1 can substitute for *E. coli* HypC.

The operons encoding HypA1-X and HypA2-X can also rescue the hydrogenase-null phenotype of a *hypD* mutant (Fig. [2](#Fig2){ref-type="fig"}b). However, the complementation of *E. coli hypE* and *hypF* mutants, which encode two proteins that interact extensively (Stripp et al. [@CR26]), is less compelling (Fig. [2](#Fig2){ref-type="fig"}b). The *R. eutropha* HypE1 protein (which is identically encoded in both *hypA1*-*X* and *hypA2*-*X* plasmids) is able to complement a Δ*hypE* mutant, although hydrogenase activity is clearly reduced (Fig. [2](#Fig2){ref-type="fig"}b). However, in the absence of endogenous *E. coli hypF*, it seems that *R. eutropha hypF1* is completely inactive in this assay (Fig. [2](#Fig2){ref-type="fig"}b).

Production of an active SH in *E. coli* {#Sec9}
---------------------------------------

To explore the activity of the SH, an *E. coli* host strain (HJ002) was prepared that lacked key native hydrogenase genes (Table [2](#Tab2){ref-type="table"}) and also carried an Δ*iscR* allele, which can be beneficial for heterologous production of metalloenzymes (Kelly et al. [@CR16]), and a Δ*adhE* allele, with a view to increasing the availability of the NADH substrate under fermentative conditions (Ghosh et al. [@CR11]).

The HJ002 (Δ*hyaB*, Δ*hybOA*, Δ*hycE*, Δ*iscR*, Δ*adhE*) strain was transformed with a plasmid encoding *hypA2*-*X* operon and then co-transformed with pQE80-SH or pUNI-SH. The pQE80-SH vector, when uninduced, resulted in a comparable level of MV-linked hydrogenase activity to that of the pUNI-SH (Fig. [3](#Fig3){ref-type="fig"}a). Induction with progressively higher concentrations of IPTG correlated with a corresponding increase in hydrogenase activity (Fig. [3](#Fig3){ref-type="fig"}a). This assay demonstrates that the \[NiFe\]-hydrogenase half of the SH has been assembled and activated.Fig. 3An active SH in *E. coli*. **a** *E. coli* host strain HJ002 (Δ*hyaB*, Δ*hybOA*, Δ*hycE*, Δ*iscR*, Δ*adhE*) was transformed with pUNI-PROM/pSU-PROM (−ve control); pUNI-SH/pSU-A2-X, or pQE80-SH/pSU-A2-X. Transformants were used to inoculate 500 ml LB media supplemented with 0.5% (v/v) glycerol, 0.4% (w/v) fumarate and appropriate antibiotics. The pQE80-SH containing cultures were additionally supplemented with 0, 0.25, 0.5 or 1 mM IPTG where indicated. Cultures were incubated at 37 °C overnight without shaking to induce anaerobiosis. Crude cell extracts were prepared and assayed for hydrogen-dependent reduction of methyl viologen. **b** *E. coli* strain HJ002 was transformed with either pQE80-SH or pUNI-SH together with either a control plasmid (pSU-PROM) or a plasmid carrying the synthetic *hypA1*-*X* operon or the *hypA2*-*X* operon. Transformants were used to inoculate sealed Hungate tubes containing 5 mL M9 media supplemented with 0.8% (w/v) glucose, 0.2% (w/v) casacids and appropriate antibiotics. A single end-point GC assay was used to determine the yield of hydrogen following \~72 h of incubation. *Error bars* represent SEM (*n* = 3). **c** Bacterial growth and gas chromatography was carried out as in **b**; however, 100 µM FeCl~3~ (final concentration) was added to the cultures from the outset. *Error bars* represent SEM (*n* = 3). Cultures were prepared under stringent anaerobic conditions where the media was sparged for 1.5 h with N~2~; then, in an anaerobic cabinet, Hungate tubes were filled with 5 mL of the sparged media, sealed, and finally inoculated with the strains to be tested

Next, the ability of the SH to produce H~2~ in vivo was assessed. The HJ002 (Δ*hyaB*, Δ*hybOA*, Δ*hycE*, Δ*iscR*, Δ*adhE*) strain was transformed with either pQE80-SH or pUNI-SH together with either a control plasmid (pSU-PROM) or a plasmid encoding *hypA1*-*X* or *hypA2*-*X*. Hydrogen gas in the headspace was determined by gas chromatography in a single end-point assay (Fig. [3](#Fig3){ref-type="fig"}b). The data show that there is H~2~ production from strain HJ002 carrying pQE80-SH, even without inclusion of the synthetic maturases (Fig. [3](#Fig3){ref-type="fig"}b). The native *E. coli* maturases are clearly able to assemble an active SH (Fig. [3](#Fig3){ref-type="fig"}b), thus partly corroborating the reciprocal experiment where the *R. eutropha* maturases were able to activate *E. coli* hydrogenase activity (Fig. [2](#Fig2){ref-type="fig"}). Furthermore, despite the IPTG-induced pQE80-SH strain having a similar level of MV-linked hydrogenase activity to the pUNI-SH strain (Fig. [3](#Fig3){ref-type="fig"}a), the ability to evolve H~2~ in vivo was greatly improved by using the pQE80-SH system (Fig. [3](#Fig3){ref-type="fig"}b).

During the course of this work, two further studies reported the reconstitution of SH activity in an *E. coli* host (Ghosh et al. [@CR11]; Schiffels et al. [@CR25]). In both cases, the addition of 100 µM iron salts to the growth medium was required for maximal activation of the hydrogenase (Ghosh et al. [@CR11]; Schiffels et al. [@CR25]). Thus, the synthetic operons under investigation here were also tested in growth media containing 100 µM FeCl~3~ (Fig. [3](#Fig3){ref-type="fig"}c). In this case, maximum levels of H~2~ evolution were recorded at 250 nmol H~2~ ml^−1^ OD^−1^ (Fig. [3](#Fig3){ref-type="fig"}c) compared to 12 nmol H~2~ ml^−1^ OD^−1^ without iron supplementation (Fig. [3](#Fig3){ref-type="fig"}b).

Discussion {#Sec10}
==========

Production of an active *R. eutropha* SH in *E. coli* {#Sec11}
-----------------------------------------------------

The *R. eutropha* soluble \[NiFe\]-hydrogenase enzyme is an attractive system to biotechnologists for several reasons. The SH enzyme is not membrane-bound, like so many other hydrogenases, and this lends the possibility to generate 'cell factories' producing vast quantities of active enzyme in the cell cytoplasm. In addition, the ability to link hydrogen oxidation to NAD(P)H cofactor regeneration means this enzyme could have several industrial applications working together with other NAD(P)H-dependent biochemical reactions. Finally, the natural oxygen tolerance of this enzyme (Burgdorf et al. [@CR6]) may give it an advantage as a possible H~2~ producer over the fragile O~2~-sensitive \[FeFe\]-hydrogenase class.

Recent advances have been reported in the production of the SH in *E. coli* B strains and *E. coli* K-12 strains. Both (Schiffels et al. [@CR25]) and Ghosh et al. ([@CR11]) worked with the native *R. eutropha* sequences, rather than synthetic sequences as described here, and had differing overall aims to their studies.

Schiffels et al. ([@CR25]) aimed to develop an overexpression system to allow purification of the recombinant enzyme. To this end, a plasmid-based system was constructed using the native *R. eutropha* genes for the SH and associated maturases to allow high-level production and purification of an active SH in *E. coli* BL21(DE3), a normally hydrogenase deficient strain (Pinske et al. [@CR20]). In this case, increasing extracellular nickel salts (with levels above 1 µM being inhibitory), or providing an extra nickel transporter, proved useful in increasing yield of active enzyme for purification (Schiffels et al. [@CR25]). Interestingly, Schiffels et al. ([@CR25]) found that production of an active SH was dependent on co-expression with the *R. eutropha hypA2*, *hypB2*, *hypC1*, *hypD1*, *hypE1*, and *hypF2* genes. This is in contrast to the data described here, where the *E. coli* maturases could active the SH (Fig. [3](#Fig3){ref-type="fig"}). One difference between the two studies could be that the SH expression levels induced by Schiffels et al. ([@CR25]) were likely orders of magnitude greater than achieved here. Alternatively, however, it should be noted that the BL21(DE3) strain used by Schiffels et al. ([@CR25]) may well be defective in the global regulator FNR, which is necessary for full expression of nickel uptake and *hypBCDE* in *E. coli* (Pinske et al. [@CR20]).

The work of Ghosh et al. ([@CR11]) had a similar aim to that described here---integration of an NADH-dependent \[NiFe\]-hydrogenase into *E. coli* metabolism. Ghosh et al. ([@CR11]) cloned the native SH genes behind a strong promoter and demonstrated very high (2 mol H~2~ per mole glucose) hydrogen gas production levels in an *E. coli* K-12 strain that had been deleted for native hydrogenase genes. Interestingly, in this case, the SH was able to substitute for the main alcohol dehydrogenase (AdhE) and restore growth to an *adhE* mutant under fermentative conditions (Ghosh et al. [@CR11]). Moreover, this growth effect was dependent on supplying 25 µM nickel salts to the medium (Ghosh et al. [@CR11]). The synthetic system described in this work was unable to restore fermentative growth to an *E. coli adhE* mutant on minimal media, and even the native *E. coli* K-12 control strains were unable to reach 2 mol H~2~ per mole glucose in this experimental setup. Clearly, expression levels must be very different between the Ghosh et al. ([@CR11]) experiments and those described in this work.

The work presented here used *E. coli* K-12 as a host strain and took an alternative synthetic approach to the design of the expression system. All gene sequences were designed by back-translation from protein products and arranged in synthetic operons under the control of single promoters. The modular design of the operons allows facile removal and replacement of each coding sequence, which could allow for future directed evolution or further biochemical studies. This system was found to successfully produce each individual subunit of the SH, and an active \[NiFe\]-hydrogenase was assembled that was capable of H~2~ evolution in vivo. In this system, higher level expression from the T5 promoter (pQE-80-derived) was needed to induce the highest hydrogen production levels.

On the role of maturases in the biosynthesis of \[NiFe\]-hydrogenases {#Sec12}
---------------------------------------------------------------------

One relatively surprising result reported here is that active *R. eutropha* SH could be assayed in *E. coli* in the absence of its dedicated accessory proteins, thus demonstrating that, in this system, the *E. coli* maturases could recognise and activate HoxH. This is interesting because the latter stages of cofactor insertion require some degree of protein--protein interactions, in particular when a HypC-type protein makes direct contact with the catalytic subunit. In the case of *E. coli* \[NiFe\]-hydrogenase-3, the HypC protein forms a stable complex with HycE until the cofactor loading is complete (Drapal and Böck [@CR10]). *E. coli* has a second HypC homologue, HybG that can substitute when HypC is missing (Blokesch et al. [@CR4]), and it seems also that these proteins can contribute to maturation of the SH. Indeed, the HypC protein from *Dehalococcoides mccartyi* was also recently shown to be able to activate the *E. coli* \[NiFe\]-hydrogenases (Hartwig et al. [@CR13]).

It was pleasing that the converse experiment also upheld the hypothesis of cross-talk between the different maturation systems. There, the *E. coli* hydrogenases could be activated by the synthetic maturase operons designed here. This was very important in showing that the maturases were functional. The exception was *R. eutropha* HypF1, which is an unusually truncated version of the protein, which was found to be inactive. HypF2, which is normally co-produced with the SH itself, more closely resembles the native *E. coli* protein (Wolf et al. [@CR28]). Note, however, that production of HypF1 was also not clear in the ^35^S-Met-labelling experiment (Fig. [1](#Fig1){ref-type="fig"}) and taken altogether these data show that the *hypA1*-*X* operon may not be producing an active HypF1 protein. Overall, however, these complementation experiments suggest some previously unsuspected promiscuity may exist between cofactor insertion proteins from different biological systems.

Concluding remarks {#Sec13}
==================

In this work, a synthetic biology approach has been taken to engineering additional hydrogenase biochemistry into *E. coli*. A functional *R. eutropha* SH was produced and, somewhat surprisingly, could be activated by the native maturases found in the host strain. Future work will concentrate on optimising this synthetic system and engineering further non-native hydrogenases.
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